P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography

被引：0
|
作者：
Hendrikse, NH
Bart, J
de Vries, EGE
Groen, HJM
van der Graaf, WTA
Vaalburg, W
机构：
[1] Univ Groningen Hosp, PET Ctr, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Pulm Dis, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2001年
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：48S / 54S
页数：7
相关论文
共 50 条
  • [31] P-glycoprotein inhibition increases the transport of dauricine across the blood-brain barrier
    Dong, Pei-Liang
    Han, Hua
    Zhang, Tian-Yu
    Yang, Bingyou
    Wang, Qiu-Hong
    Eerdun, Gao-Wa
    MOLECULAR MEDICINE REPORTS, 2014, 9 (03) : 985 - 988
  • [32] Single photon emission computed tomography and positron emission tomography imaging of multi-drug resistant P-glycoprotein - Monitoring a transport activity important in cancer, blood-brain barrier function and Alzheimer's disease
    Piwnica-Worms, David
    Kesarwala, Aparna H.
    Pichler, Andrea
    Prior, Julie L.
    Sharma, Vijay
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2006, 16 (04) : 575 - +
  • [33] High glucose reduces P-glycoprotein transport activity at the blood-brain barrier
    Chan, Gary N. Y.
    Goldstein, Joyce A.
    Miller, David S.
    DRUG METABOLISM REVIEWS, 2016, 48 : 146 - 146
  • [34] Impact of P-glycoprotein on the efficiency of carbamazepine transport across the blood-brain barrier
    Zybina, A.
    Kulichenkova, K.
    Abbasova, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S197 - S197
  • [35] Oseltamivir (Tamiflu™) efflux transport at the blood-brain barrier via P-glycoprotein
    Morimoto, Kaori
    Nakakariya, Masanori
    Kanauchi, Itaru
    Shirasaka, Yoshiyuki
    Tamai, Ikumi
    Ogihara, Takuo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 111 - 112
  • [36] A Method of Analysis of the Functional Activity of P-Glycoprotein in the Blood-Brain Barrier
    Chernykh, I. V.
    Shchul'kin, A. V.
    Myl'nikov, P. Yu.
    Gatsanoga, M. V.
    Popova, N. M.
    Yakusheva, E. N.
    NEUROCHEMICAL JOURNAL, 2019, 13 (01) : 105 - 109
  • [37] The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery
    Cox, Benoit
    Nicolai, Johan
    Williamson, Beth
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (01) : 113 - 126
  • [38] Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier
    Miller, David S.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (06) : 246 - 254
  • [39] Quantitative Investigation of the Impact of P-Glycoprotein Inhibition on Drug Transport across Blood-Brain Barrier in Rats
    Sugimoto, Hiroshi
    Hirabayashi, Hideki
    Kimura, Yoshiaki
    Furuta, Atsutoshi
    Amano, Nobuyuki
    Moriwaki, Toshiya
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (01) : 8 - 14
  • [40] Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability
    O'Brien, Fionn E.
    Clarke, Gerard
    Dinan, Timothy G.
    Cryan, John F.
    Griffin, Brendan T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (10): : 2259 - 2272
12345